BIOMIND LABS INC.

Press Releases Biomind Labs Inc. OTC Markets

Equities

CRSWF

CA0907021012

Market Closed - OTC Markets Other stock markets 10:05:47 2024-06-25 EDT			5-day change	1st Jan Change
0.1633 ^USD	+43.12%		0.00%	-83.67%

05-31	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Canadian Investment Regulatory Organization Trade Resumption - BMND	06-04	AQ
Canadian Investment Regulatory Organization Trading Halt - BMND	04-09	AQ
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications	23-09-14	BU
Biomind Labs Announces the Completion of the First Sublingual Formulation for Its BMND08 Candidate for Depression and Anxiety in Alzheimer's Disease	22-12-29	AQ
Biomind and Queen's University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System	22-09-28	AQ
Biomind Labs Doses First Subject in Phase I/IIa Clinical Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression	22-04-26	BU
Biomind Labs to Present at Benzinga Psychedelics Capital Conference in the U.S. on April 19th 2022	22-03-31	AQ
Biomind Labs Receives Approval for a Second Phase II Clinical Trial for Treatment-resistant Depression	22-03-09	BU
Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form	21-11-18	BU
Biomind Labs : to Advance a Phase II Clinical Trial on DMT for Treatment-Resistant Depression	21-08-18	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer